4,126 Shares in Cutera, Inc. (NASDAQ:CUTR) Bought by Arizona State Retirement System

Arizona State Retirement System purchased a new position in Cutera, Inc. (NASDAQ:CUTRGet Rating) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,126 shares of the medical device company’s stock, valued at approximately $285,000.

A number of other institutional investors also recently bought and sold shares of CUTR. Millennium Management LLC increased its stake in Cutera by 66.7% in the fourth quarter. Millennium Management LLC now owns 708,966 shares of the medical device company’s stock worth $29,294,000 after purchasing an additional 283,736 shares during the period. Dimensional Fund Advisors LP increased its stake in Cutera by 1.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 402,034 shares of the medical device company’s stock worth $16,611,000 after purchasing an additional 4,832 shares during the period. Paradigm Capital Management Inc. NY increased its stake in Cutera by 38.1% in the fourth quarter. Paradigm Capital Management Inc. NY now owns 319,100 shares of the medical device company’s stock worth $13,186,000 after purchasing an additional 88,000 shares during the period. Adage Capital Partners GP L.L.C. increased its stake in Cutera by 20.0% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 300,000 shares of the medical device company’s stock worth $12,396,000 after purchasing an additional 50,000 shares during the period. Finally, Emerald Advisers LLC purchased a new stake in Cutera in the first quarter worth $19,253,000.

Cutera Price Performance

CUTR opened at $48.37 on Friday. The business’s 50-day moving average is $41.56 and its two-hundred day moving average is $46.29. Cutera, Inc. has a 1 year low of $31.62 and a 1 year high of $74.38. The company has a debt-to-equity ratio of 3.12, a current ratio of 3.20 and a quick ratio of 2.50. The firm has a market capitalization of $878.54 million, a PE ratio of -64.49 and a beta of 1.86.

Cutera (NASDAQ:CUTRGet Rating) last posted its earnings results on Tuesday, May 10th. The medical device company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.75). Cutera had a negative net margin of 5.31% and a negative return on equity of 24.42%. The company had revenue of $58.01 million during the quarter, compared to analysts’ expectations of $57.26 million. During the same quarter last year, the firm earned ($0.02) EPS. Cutera’s revenue for the quarter was up 16.8% on a year-over-year basis. Research analysts anticipate that Cutera, Inc. will post -1.14 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. StockNews.com lowered Cutera from a “hold” rating to a “sell” rating in a research note on Thursday, May 12th. Maxim Group raised their price target on Cutera from $60.00 to $80.00 in a research note on Thursday, May 5th. TheStreet lowered Cutera from a “c-” rating to a “d+” rating in a research note on Thursday, July 7th. Finally, Stephens raised their price target on Cutera from $68.00 to $78.00 in a research note on Monday, May 9th.

Insider Buying and Selling at Cutera

In other Cutera news, CEO David H. Mowry purchased 996 shares of the stock in a transaction on Friday, May 13th. The stock was acquired at an average price of $50.12 per share, with a total value of $49,919.52. Following the completion of the acquisition, the chief executive officer now owns 131,779 shares in the company, valued at $6,604,763.48. The acquisition was disclosed in a filing with the SEC, which is available at this link. 2.10% of the stock is owned by insiders.

Cutera Profile

(Get Rating)

Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.

Further Reading

Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTRGet Rating).

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Want More Great Investing Ideas?

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.